Investment Management Corp of Ontario

Position in NBIX — Neurocrine Biosciences Inc

CIK 1811568 Toronto, Z4

Back to NBIX Full portfolio

Position in NBIX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,021,183

+$78,057 QoQ

Shares Held

6,059

-15.4% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#395

of 768 holders

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Investment Management Corp of Ontario holds $6,958,430 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (14.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	72,660	$2,461,720
2	ZTS	Zoetis Inc.	26,796	$1,925,560
3	UTHR	UNITED THERAPEUTICS Corp	2,516	$1,363,244
4	NBIX	Neurocrine Biosciences Inc This page	6,059	$1,021,183
5	BHC	Bausch Health Companies Inc.	37,875	$186,723

All Filings in NBIX

Export CSV

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,021,183	6,059	-15.4%	Shares	Sole	2026-08-14
2026-03-31	$943,126	7,159	+7.5%	Shares	Sole	2026-05-15
2025-12-31	$944,445	6,659	+43.4%	Shares	Sole	2026-02-17
2025-09-30	$652,065	4,645	-38.3%	Shares	Sole	2025-11-14
2025-06-30	$946,571	7,531	-5.0%	Shares	Sole	2025-08-14
2025-03-31	$877,168	7,931	+72.8%	Shares	Sole	2025-05-15
2024-12-31	$626,535	4,590	-3.9%	Shares	Sole	2025-02-14
2024-09-30	$550,521	4,778	+33.5%	Shares	Sole	2024-11-14
2024-06-30	$492,583	3,578	+20.1%	Shares	Sole	2024-08-14
2024-03-31	$410,725	2,978	-19.0%	Shares	Sole	2024-05-15
2023-12-31	$484,613	3,678	-60.7%	Shares	Sole	2024-02-14
2022-12-31	$1,118,077	9,361	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.